Accelerating Drug Development for COVID-19: A Race against the Pandemic

The COVID-19 pandemic necessitated an urgent and accelerated approach to drug development. This abstract highlights the remarkable efforts made in developing drugs for COVID-19, including collaboration among scientists, repurposing existing drugs, and the triumph of vaccine development. The global scientific community joined forces, sharing knowledge and data to understand the virus better. Repurposing existing drugs allowed for faster clinical trials and promising results. The development and distribution of vaccines became a historic achievement, significantly reducing the spread and severity of the virus. Challenges such as safety assessments and equitable distribution were encountered. Lessons learned from this endeavor will shape future drug development and global pandemic preparedness. The COVID-19 drug development race showcases human resilience, scientific advancement, and the power of collaboration.

Keywords

Covid-19; Drug development; Existing drugs

மறுப்பு: இந்த சுருக்கமானது செயற்கை நுண்ணறிவு கருவிகளைப் பயன்படுத்தி மொழிபெயர்க்கப்பட்டது மற்றும் இன்னும் மதிப்பாய்வு செய்யப்படவில்லை அல்லது சரிபார்க்கப்படவில்லை

ஃபார்மகாலஜியா மற்றும் டாக்ஸிகோலாஜியா

குறியிடப்பட்டது

இந்தப் பக்கத்தைப் பகிரவும்

சுருக்கம்

Accelerating Drug Development for COVID-19: A Race against the Pandemic